Sheena McCormack, Medical Research Council Clinical Trials Unit, UK. Co-principal Investigator, Microbicides Development Programme. Sheena McCormack, MBBS, MSc, FRCP, Dip Ven., is a Clinical Epidemiologist who has been coordinating HIV prevention trials since 1994, when she joined what has subsequently become the MRC Clinical Trials Unit. From the outset she has worked on HIV vaccine trials, all Phase I/II, in Europe and Africa. Since 1998 she has been involved in microbicide trials and is co-PI of the Microbicides Development Programme (MDP), a multi-disciplinary public-private partnership. She was Chief Investigator of the Phase III clinical trial that enrolled 9,385 women through six research centres in Southern Africa and reported in 2009. Research collaborations include vaccine networks (EuroVac, AfrEVac, TaMoVac and UK HVC), microbicide networks (MDP and three EDCTP-funded networks: Mozambique-South Africa, Tanzania-Uganda, and Biomarkers), and prevention networks (Europrise and PopART). Sheena has been a Consultant in HIV/GU Medicine since 1991, initially at the Royal Devon and Exeter Hospitals and since 1996 at Chelsea & Westminster Hospital working at the Dean Street clinic in Soho. She is working with colleagues to determine the role of PrEP in the UK HIV prevention strategy following the demonstration of a reduced risk of acquisition in gay men allocated Truvada compared to placebo. She has been a Reader in Clinical Epidemiology at Imperial College since 2008.
Biography Updated on 1 April 2012